BRP, identified through peptide prediction, may revolutionize weight loss treatment, offering efficacy without the ...

G lucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have ...

Retatrutide mimics the effects of naturally occurring gut hormones to improve metabolic health. Stimulating insulin release ...

Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

This study provides valuable guidance for doctors and patients when choosing diabetes medications. It confirms that ...

A LOVED-UP mum’s bid to shine in her wedding dress went wrong after using a pharmacy-bought ‘fat jab’. Stephanie Hill decided ...

The global antidiabetics market is on a strong growth trajectory, with sales projected to soar from USD 106.3 billion in 2024 to USD 298.2 billion by 2034. This substantial increase reflects a robust ...

Novo Nordisk, for instance, developed the drug liraglutide, which was a daily injection, and long-acting GLP-1 agonists such as semaglutide, a weekly injection. As well as increasing insulin from the ...

VANCOUVER, BC, CANADA, March 6, 2025 /EINPresswire / -- The latest market intelligence study, called“Global Insulin Market Forecast to 2028,” jots down some of the most prominent growth ...

Glucagon-like peptide-1 (GLP-1) drugs mimic the GLP-1 hormone, which helps control insulin and blood sugar levels, decreases appetite and slows digestion of food. Both diabetes and obesity increase ...

Meanwhile, the double positive staining of both insulin and glucagon were observed, suggesting the islet cell transdifferentiation. Moreover, there also exist the β-cell to α-cells ...